封面
市場調查報告書
商品編碼
1606267

近距離放射治療市場:按適應症、產品、劑量類型、最終用戶分類 - 2025-2030 年全球預測

Brachytherapy Market by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer), Offering (Devices, Services), Dosage Type, End User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年近距離放射治療市場價值為9.6201億美元,預計到2024年將達到10.1287億美元,複合年成長率為5.75%,預計到2030年將達到14.2357億美元。

近距離放射治療是體內放射治療的一種形式,是主要用於癌症的重要治療方法。這種方法可以精確傳遞高劑量的輻射,同時最大限度地減少對周圍健康組織的暴露。近距離放射治療的需求是顯而易見的,因為與外部束放射相比,近距離放射治療具有針對性、高效的治療效果,且治療時間更短,這使得它對治療前列腺癌、子宮頸癌、乳癌和皮膚癌至關重要。最終用途包括醫院、專門的癌症治療中心和門診病人設施。市場成長是由新興國家的技術進步、癌症發生率增加和醫療基礎設施擴大所推動的。在近距離放射治療中採用影像引導和機器人技術是提高治療準確性和患者治療效果的關鍵成長要素。新的商機在於利用人工智慧和機器學習來製定更個人化的治療計劃並改善放射性崩壞的即時監測。此外,世界日益老化的人口由於對癌症的易感性而呈現出相當大的成長潛力。然而,該市場面臨初始設備成本高、監管複雜性以及缺乏接受過近距離放射治療技術培訓的熟練專業人員等限制,這可能會阻礙廣泛採用。由於對近距離放射治療的認知和理解有限,患者也面臨焦慮的挑戰。創新應側重於具有成本效益的解決方案和教育計劃,以提高醫療保健提供者和患者的認知。研究和開發可以推進到攜帶式和更緊湊的設備的開發,以使近距離放射治療可以在偏遠和資源有限的地區使用,從而擴大近距離放射治療的使用範圍。此外,與學術機構合作進行先進的放射性同位素研究也是有益的。總體而言,該市場有望實現顯著成長,但為了充分發揮其潛力,重要的是透過策略創新和夥伴關係關係克服現有挑戰。

主要市場統計
基準年[2023] 96201萬美元
預計年份 [2024] 1,012,870,000 美元
預測年份 [2030] 1,423.57 百萬美元
複合年成長率(%) 5.75%

市場動態:揭示快速發展的近距離放射治療市場的關鍵市場洞察

供給和需求的動態交互作用正在改變近距離放射治療市場。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球癌症發生率上升以及有效治療的需求
    • 以疾病的早期診斷和治療為目標
    • 人們越來越偏好微創醫療程序
  • 市場限制因素
    • 近距離放射治療的高成本和複雜性
  • 市場機會
    • 利用個人化醫療方法提供精準治療
    • 持續研究和開發以提高近距離放射治療的有效性
  • 市場挑戰
    • 嚴格的法律規範和缺乏熟練的專業人員

波特五力:駕馭近距離放射治療市場的策略工具

波特五力是了解近距離放射治療市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰,以確保更強大的市場地位。

PESTLE分析:了解近距離放射治療市場的外部影響

外部宏觀環境因素在塑造近距離放射治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。

市場佔有率分析 了解近距離放射治療市場的競爭狀況

對近距離放射治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣近距離治療市場供應商的績效評估

FPNV定位矩陣是評估近距離放射治療市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了近距離放射治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說,近距離放射治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機,並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的癌症發生率正在上升,增加了對有效治療的需求。
      • 疾病的早​​期診斷和治療趨勢
      • 人們對微創醫療程序的興趣日益濃厚
    • 抑制因素
      • 近距離放射治療的高成本和複雜性
    • 機會
      • 利用個人化醫療方法提供精準治療
      • 持續研究和開發以提高近距離放射治療的有效性
    • 任務
      • 嚴格的法規結構和缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章近距離放射治療市場(依適應症)

  • 乳癌
  • 婦科癌症
  • 攝護腺癌

第7章近距離放射治療市場:透過提供

  • 裝置
    • 後荷機
    • 施用器
    • 種子
  • 服務

第8章按劑量類型分類的近距離放射治療市場

  • 高劑量率 (HDR) 近距離放射治療
  • 低劑量率 (LDR) 近距離放射治療

第 9 章近距離放射治療市場:依最終用戶分類

  • 醫院
  • 專科診所

第10章美洲近距離放射治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區近距離放射治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲近距離放射治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Accuray Incorporated
  • BEBIG Medical GmbH
  • Becton, Dickinson and Company
  • Best Medical International, Inc.
  • BWX Technologies. Inc.
  • CivaTech Oncology Inc.
  • CIVCO Medical Solutions
  • Eckert & Ziegler Radiopharma GmbH
  • Elekta AB
  • GammaTile
  • Healvita Group GmbH
  • Hologic, Inc.
  • iCAD, Inc.
  • IsoAid, LLC
  • Isoray Medical, Inc. by Perspective Therapeutics
  • Mick Radio-Nuclear Instruments, Inc.
  • Mirion Technologies, Inc.
  • Nihon Medi-Physics Co., Ltd.
  • Qfix
  • Theragenics
  • Varian Medical Systems, Inc.
Product Code: MRR-521BAA36EB3B

The Brachytherapy Market was valued at USD 962.01 million in 2023, expected to reach USD 1,012.87 million in 2024, and is projected to grow at a CAGR of 5.75%, to USD 1,423.57 million by 2030.

Brachytherapy, a form of internal radiation therapy, is a critical treatment modality primarily used for cancer, involving placing radioactive material directly within or next to a tumor. This approach allows for high-dose radiation delivery with precision, minimizing exposure to surrounding healthy tissue. The necessity of brachytherapy is evident in its targeted efficiency and reduced treatment times compared to external beam radiation, making it integral in treating prostate, cervical, breast, and skin cancers. The end-use scope extensively covers hospitals, specialized cancer treatment centers, and outpatient facilities. Market growth is driven by technological advancements, increasing cancer prevalence, and expanding healthcare infrastructure in emerging economies. The adoption of image-guided and robotic technologies in brachytherapy is a key growth factor, enhancing treatment accuracy and patient outcomes. Emerging opportunities lie in leveraging AI and machine learning to develop more personalized treatment plans and improve real-time monitoring of radioactive decay. Additionally, the rise in geriatric populations worldwide presents considerable growth potential, given their higher susceptibility to cancer. However, the market faces limitations such as high initial equipment costs, regulatory complexities, and a shortage of skilled professionals trained in brachytherapy techniques, which can hinder adoption. There's also a challenge in patient apprehension due to limited awareness and understanding of brachytherapy. Innovations should focus on cost-effective solutions and educational programs to raise awareness among healthcare providers and patients. Research can expand into developing portable or more compact devices to make brachytherapy accessible in remote and resource-limited areas, thus broadening its reach. Moreover, collaborations with academic institutions for research in advanced radioactive isotopes can prove beneficial. Overall, while the market is poised for substantial growth, overcoming existing challenges through strategic innovations and partnerships will be crucial for capitalizing on its full potential.

KEY MARKET STATISTICS
Base Year [2023] USD 962.01 million
Estimated Year [2024] USD 1,012.87 million
Forecast Year [2030] USD 1,423.57 million
CAGR (%) 5.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brachytherapy Market

The Brachytherapy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cancer worldwide and need for efficient treatment
    • Inclination toward early diagnosis and treatment of diseases
    • Increasing preference for minimally invasive medical procedures
  • Market Restraints
    • High cost and complexity in brachytherapy
  • Market Opportunities
    • Utilization of personalized medicine approach to deliver precise treatment
    • Ongoing R&D to enhance the efficacy of brachytherapy
  • Market Challenges
    • Stringent regulatory framework and dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Brachytherapy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brachytherapy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brachytherapy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brachytherapy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brachytherapy Market

A detailed market share analysis in the Brachytherapy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brachytherapy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brachytherapy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brachytherapy Market

A strategic analysis of the Brachytherapy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brachytherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, BEBIG Medical GmbH, Becton, Dickinson and Company, Best Medical International, Inc., BWX Technologies. Inc., CivaTech Oncology Inc., CIVCO Medical Solutions, Eckert & Ziegler Radiopharma GmbH, Elekta AB, GammaTile, Healvita Group GmbH, Hologic, Inc., iCAD, Inc., IsoAid, LLC, Isoray Medical, Inc. by Perspective Therapeutics, Mick Radio-Nuclear Instruments, Inc., Mirion Technologies, Inc., Nihon Medi-Physics Co., Ltd., Qfix, Theragenics, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Brachytherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Breast Cancer, Gynecological Cancer, and Prostate Cancer.
  • Based on Offering, market is studied across Devices and Services. The Devices is further studied across Afterloaders, Applicators, and Seeds.
  • Based on Dosage Type, market is studied across High-Dose Rate (HDR) Brachytherapy and Low-Dose Rate (LDR) Brachytherapy.
  • Based on End User, market is studied across Hospitals and Specialty Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer worldwide and need for efficient treatment
      • 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
      • 5.1.1.3. Increasing preference for minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complexity in brachytherapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Utilization of personalized medicine approach to deliver precise treatment
      • 5.1.3.2. Ongoing R&D to enhance the efficacy of brachytherapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework and dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Brachytherapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Breast Cancer
  • 6.3. Gynecological Cancer
  • 6.4. Prostate Cancer

7. Brachytherapy Market, by Offering

  • 7.1. Introduction
  • 7.2. Devices
    • 7.2.1. Afterloaders
    • 7.2.2. Applicators
    • 7.2.3. Seeds
  • 7.3. Services

8. Brachytherapy Market, by Dosage Type

  • 8.1. Introduction
  • 8.2. High-Dose Rate (HDR) Brachytherapy
  • 8.3. Low-Dose Rate (LDR) Brachytherapy

9. Brachytherapy Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinic

10. Americas Brachytherapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Brachytherapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Brachytherapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. BEBIG Medical GmbH
  • 3. Becton, Dickinson and Company
  • 4. Best Medical International, Inc.
  • 5. BWX Technologies. Inc.
  • 6. CivaTech Oncology Inc.
  • 7. CIVCO Medical Solutions
  • 8. Eckert & Ziegler Radiopharma GmbH
  • 9. Elekta AB
  • 10. GammaTile
  • 11. Healvita Group GmbH
  • 12. Hologic, Inc.
  • 13. iCAD, Inc.
  • 14. IsoAid, LLC
  • 15. Isoray Medical, Inc. by Perspective Therapeutics
  • 16. Mick Radio-Nuclear Instruments, Inc.
  • 17. Mirion Technologies, Inc.
  • 18. Nihon Medi-Physics Co., Ltd.
  • 19. Qfix
  • 20. Theragenics
  • 21. Varian Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. BRACHYTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. BRACHYTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BRACHYTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BRACHYTHERAPY MARKET DYNAMICS
  • TABLE 7. GLOBAL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BRACHYTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BRACHYTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BRACHYTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HIGH-DOSE RATE (HDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BRACHYTHERAPY MARKET SIZE, BY LOW-DOSE RATE (LDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BRACHYTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BRACHYTHERAPY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023